Events | MSK Innovations

Coming Up Next

Register now to attend our upcoming events and join a community of like-minded individuals passionate about investing in MSK. We look forward to seeing you there!

Past Events

View recordings of previous events at MSK Innovations

May 8th | Abanza, Spinol, Sonogen

John Rizzo, EVP - ABANZA Medical http://www.abanzamed.com

WasherCap - The design and components (Cap, Screw and Washer) of the WasherCap allows a complete entrapment of the soft-tissue graft inside the device, so there is no dependance on the quality of the patient’s cancellous bone. WasherCap™ is the best ally for a safe and reliable soft-tissue graft fixation.

Roey Shafrir, CEO - Spinol Medical https://spinolmedical.com/

OctaSeal is the only annulus closing implant designed for micro-discectomy It addresses a wide range of rupture sizes and takes under 3 minutes to implant

Jason Winder, CEO - Sonogen Medical https://sonogenmed.com

Sonogen has combined decades of experience in fluid mechanics and biophysics with extensive experience in sonar and medical ultrasound to develop the next generation of safe and effective ultrasound-based bone fracture healing devices.

June 5th | APEX, TrackX, Unify

Jim Rogers, CEO - APEX Biologix: https://www.apexbiologix.com

APEX Biologix is dedicated to the science and research of autologous orthobiologics. The products include XCell PRP, BMC, and Protein Concentrator. Our mission is to help patients get back to work or play by enabling their own bodies to heal faster and more completely through our innovative products and processes.

Robert Issacs, MD, CEO - TrackX: https://www.trackx.tech/

TrackX is a simple, accurate and efficient universal instrument tracking technology that provides real-time virtual live fluoroscopy and re-calibrates with every new x-ray. No bulky equipment, no capital purchases and no trays or instruments requiring sterilization - simply attach a disposable TrackX Snap and start tracking within seconds.

Rick Kovach, CEO - Unify Medical: https://unifymedical.com/

Unify Medical develops novel imaging and visualization technologies for the benefit of surgeons with a primary focus on image-guided surgical procedures. Unify’s platform integrates 3D, high-definition images, and intraoperative information, giving surgeons a clear view of the operative field and real-time data to make intelligent decisions. This technology unifies the view of the surgeon and the surgical team and forges close collaboration and communication within the OR.

July 10th | MY01, Spark Spine, Sail Fusion

Andrew Morris, CCO - MY01: https://my01.io/

The MY01 platform is designed to continuously monitor intracompartmental pressure to provide real-time, actionable insights for proactive risk management of compartment syndrome. MY01 enables precise, personalized care by delivering real-time, actionable insights and connecting healthcare teams to improve patient outcomes.

Luke Diehl, VP Business Development - Spark Spine: https://www.sparkspine.com/

Spark Spine is creating a novel biomimetic platform technology to achieve a new type of cellular signaling.

David Jansen, CEO - Sail Fusion: https://sailspine.com/

SAIL Fusion is committed to providing lasting relief for patients with chronic lower back pain caused by the sacroiliac (SI) joint, using proven AO principles and its FDA cleared BowTie technology to enable true and robust SI joint fusion.

August 7th | Reach Orthopaedics, NSite Medical, Cambridge Orthopaedic Labs

Reach Orthopaedics - Christina Goudy, CEO

Reach Orthopaedics is developing a shoulder implant to treat middle-aged patients suffering from massive irreparable rotator cuff tears. Founded by orthopaedic surgeons, their patent approved device design aims to restore shoulder function and reduce chronic pain.

NSite Medical - Michael Gardner, MD, CEO

NSite Medical is dedicated to enhancing patient care and experiences for individuals affected by Scoliosis. Through innovative programs and advanced screening technology, NSite Medical proactively treats scoliosis, offering specialized solutions for both children and adults.

Cambridge Orthopaedic Labs - David Anderson, CEO

Cambridge Orthopaedic Labs is a medical device company that has developed a transformational way of treating bone fractures, with PolyArmour technology - a non invasive external fixator. Removing the need for costly and invasive operative procedures.

September 4th | Endeavor Orthopaedics, SentryX, PathKeeper

Endeavor Orthopaedics - Greg Parranto, CEO

Endeavor Orthopaedics is an IP-protected platform technology company focused on treating avulsion fractures by integrating fracture repair with soft tissue management in a single sterile implant. The company’s first FDA-cleared and commercially available product is the Summit Patella Plating System, with future products planned for the elbow, shoulder, and hip. These target just over 9% of the 6.5 million fractures occurring annually in the U.S., representing a market value of over $2 billion. The company has successfully conducted 85 surgeries to date.

SentryX - Hein Jonkman, VP Strategy

SentryX is a clinical-stage biopharmaceutical company aiming to revolutionize pain management after major surgery. Using highly innovative biomaterials, it develops non-opioid local pain treatments that are easy to use and cover the critical first three days of recovery, helping patients get back on their feet quicker and in better shape.

PathKeeper Surgical

PathKeeper was co-founded by a HSS trained spine surgeon in Israel frustrated by current robotic and navigation systems, and a medical 3-D camera engineering expert. Their mission is to support spine surgeons with an advanced “Active” navigation system that provides a higher value (and lower cost) than current systems. PK has developed a disruptive, real-time, radiation-free spine navigation system that provides physicians with a high level of surgical accuracy. Utilizing AI algorithms and optical imaging, the proprietary 3D camera refreshes 15x per second, giving the surgeon real time feedback, regardless of patient movement or movement of reference frames.

October 2nd | Askel Healthcare, Kleiner Device Labs, OSSTEC

Askel Healthcare - Ted Bird, Chairman of the Board

Askel Healthcare is a Finnish medical technology company set to transform surgical knee cartilage treatment and recovery. Askel's innovative solution, the COPLA® Cartilage Implant, is designed to address the fundamental issues that plague current treatment options, offering a more effective and patient-friendly alternative for cartilage repair. Their vision is to become the global standard of first-line surgical knee cartilage repair.

Kleiner Device Labs - Jeff Kleiner, CEO

Kleiner Device Labs (KDL) is a medical technology company dedicated to transforming spinal surgical procedures and outcomes. KDL's innovative solutions, including the KG™1 graft delivery system and KG™2 Surge™ Flow-Thru Interbody Implant, address fundamental issues in current spinal surgery instrumentation, offering more efficient, safer, and cost-effective alternatives for spinal fusion. KDL has a broad patent portfolio and a runway of innovative minimally invasive spinal surgical products.

OSSTEC - Maxwell Munford, CEO

OSSTEC has developed an additive manufacturing bone healing technology, currently applied in partial knee implants. Their implants stimulate long-term bone growth to resolve common sources of failure: loosening and bone loss. OSSTEC's vision is to keep patients active, pain-free and enjoying added years of improved quality of life.

November 6th | ZygoFix, CytexOrtho, Indius Medical

ZygoFix - Ofer Levy, CEO

ZygoFix has developed a proprietary approach to spinal stabilization and spinal fusion. The company's zLOCK system utilizes our spine’s natural anatomy for spinal stability. The system offers all around benefits to the $2.2 billion worldwide addressable spine market.

CytexOrtho - Brad Estes, CEO

CytexOrtho is developing an absorbable orthopedic implant designed to treat early hip disease in young/active patients, offering a much-needed solution for a growing population that currently lacks effective treatment options.

Indius Medical - Aditya Ingalhalikar, CEO

INDIUS has developed Patient Specific Growth Rods, an innovative solution for treating children with spinal scoliosis, reducing the need for multiple surgeries. INDIUS’s technology enables daily growth response, addressing a critical need in pediatric scoliosis care. The company holds global IP for this groundbreaking solution.

December 4th | Nanochon, Orthomod, Allumin8

Nanochon - Ben Holmes, CEO

Nanochon is a medical device company focused on developing innovative cartilage repair technologies using advanced 3D printing and nanomaterial polymers. Their flagship product, the Chondrograft™, is designed to provide both immediate structural support and promote natural tissue regeneration for joint repair. Nanochon aims to revolutionize orthopedic care by offering less invasive, more durable alternatives to traditional joint replacement surgeries, improving recovery outcomes for patients, and addressing the cost and difficulty of the standards of care for sports medicine surgeons.

Orthomod - David Kirschman CEO

Orthomod is developing regenerative orthopedic implants to improve patient outcomes using novel structural biomaterials. Orthomod addresses the limitations of existing orthopedic implants that lack both strength and bone-healing properties- leading to failure, costly revisions, and long recovery times. Its CAMP material promotes bone ingrowth and fusion while maintaining full load-bearing integrity, offering a durable, osteoactive alternative to materials like PEEK, titanium, or bone grafts in the $50B+ orthopedic implant market. Orthomod currently has two FDA 510(k) applications pending for spinal and cranial applications, and will set a new standard for orthopedic solutions.

Allumin8 - Alyssa Huffman, CEO

Introducing a new category of Therapeutic Orthopedic & Spine 3D Hardware designed to reduce global reoperation rates. Our advanced porous solutions provide surgeons with innovative pathways to diagnose, treat, and heal through the devices, enhancing patient outcomes with the highest level of clinical evidence and cutting-edge technology.

January 8th | Arcuro Medical, Sterile Processing Express, Native Orthopedics

Arcuro Medical - Jamal Rushdy, CEO

Arcuro Medical, with operations in the U.S. and cutting-edge R&D facilities in Israel, has created the innovative SuperBall™, an advanced all-inside suture device that enables superior meniscus repair with precise surgical control.

Sterile Processing Express - Julius F. Heil, CEO

SPDx provides a comprehensive sterile processing service, delivering manufacturer-owned instrument trays to surgical facilities on a per-case basis. The company manages the entire cycle - from delivery and retrieval to sterilization at their processing facility.

Native Orthopaedics - TOM GAMACHE, CEO

Native develops innovative knotless fixation technology for orthopedic surgery. Their minimally invasive platform aims to restore native anatomy while reducing Osteoarthritis progression, with applications across multiple suspensory fixation procedures.

February 5th | Flowbone, RELJA, NEXILIS

Flowbone - Régis Gauderon, CEO

Flowbone's injectable gel offers a revolutionary approach to strengthening fragile bones by stimulating the body's natural mineral deposition process, transforming into viable bone tissue without introducing foreign materials. The minimally invasive procedure involves injecting the gel via cannula into high-risk bone regions, promoting natural bone formation without interfering with bone vascularization and biomechanics.

RELJA - Rob Amiot, CEO

RELJA is a medical device company that has developed and commercialized four FDA-cleared, IP-protected minimally invasive bunion surgery products. Led by an experienced executive team with extensive foot and ankle industry expertise, RELJA's products offer surgeons a comprehensive solution that reduces operating time and costs while providing less invasive treatment options for patients.

NEXILIS - Leanna Caron, CEO

NEXILIS has developed a progressive technology that improves implant stabilization in patients with poor bone quality through better and more reliable anchorage of fixation screws in bone. Their immediate stabilization system (ISS) creates a significantly improved interface between screws and surrounding bone, establishing the foundation for a safe healing process and durable treatment effect.

Register for Future Events

Please complete the form to be included in our next event.